Clinical Trials

The CLARIT trial has reached an important milestone with the enrollment of its first patients in Spain. The first three patients were enrolled by Dr. Alfonso Jurado Román and the team at La Paz University Hospital in Madrid, marking the start of patient recruitment in Spain for this international...

We are pleased to celebrate another important milestone in the LNB Study! Congratulations to Prof. Dr. Holger Nef and the team in Herz- und Gefäßzentrum Segeberger Kliniken Gruppe on enrolling their first patient in the study. This marks an exciting step forward and reflects the team's commitment to...

We are proud to announce the successful completion of patient enrollment in the VITUS study. This important milestone reflects the dedication, collaboration, and commitment of all participating investigators, study coordinators, and site teams who made this achievement possible. A sincere thank you...

A key milestone that marks strong momentum for the study across participating countries. Congratulations to Dr. Nishant Gangil, Dr. Thirumaran Rajathurai and the cath lab team at University Hospitals Coventry and Warwickshire (UHCW) NHS Trust for this achievement. A great step forward driven by...

We are pleased to announce the inclusion of the first two patients in the TACTIC study. The first patient was enrolled by Prof Alaide Chieffo from Ospedale San Raffaele, Milan, followed by a second inclusion by Dr Mario Iannaccone from San Giovanni Bosco Hospital, Turin. TACTIC study is an...

We are pleased to announce the successful treatment of the first patient in the FIH IPERF-01 first-in-human study. This clinical investigation evaluates the IPERF femoral arterial cannula, an innovative device featuring a novel dual-flow technology designed to enable simultaneous perfusion of the...

CYCLOPES Trial Design and Rationale Published CERC is pleased to announce the publication of the design and rationale of the CYCLOPES Trial. The article details the scientific background, objectives, and study design of CYCLOPES, study, providing transparency on the trial’s methodological approach...

CERC is proud to share that TARGET FIRST and SELUTION DeNovo , both conducted with CERC, have been selected among the Top 10 studies in interventional cardiology in 2025 by the European Heart Journal. CERC is proud to share that TARGET FIRST and SELUTION DeNovo, both conducted with CERC, have been...

We are proud to share that the ALL WOMEN study has successfully reached its enrollment goal, and patient inclusion is now completed. Thank you to everyone involved for your strong commitment and teamwork. The next focus is data completion for primary endpoint communications. Learn more about the ALL...

CERC is proud to support the publication of clinical trial results, working closely with investigators and sponsors to ensure high-quality scientific output and visibility in leading peer-reviewed journals. In 2025, CERC-supported studies resulted in 15 publications in major international journals...